| 12.7 |
38.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 8.0 |
40.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 8.0 |
24.0 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 8.0 |
39.8 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 7.9 |
23.6 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 7.4 |
22.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 7.0 |
21.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 6.2 |
18.5 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 5.9 |
135.9 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 5.6 |
22.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 5.6 |
16.7 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 5.5 |
11.1 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 5.5 |
60.7 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 5.4 |
48.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 5.4 |
16.1 |
GO:1905065 |
hematopoietic stem cell migration(GO:0035701) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 5.2 |
15.6 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 4.8 |
14.5 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 4.7 |
14.0 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 4.6 |
13.8 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 4.6 |
13.7 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 4.5 |
17.8 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 4.3 |
12.8 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 4.2 |
16.8 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 4.1 |
20.7 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 4.1 |
20.6 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 4.1 |
8.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 4.0 |
16.1 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 4.0 |
16.1 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 4.0 |
12.0 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 3.8 |
19.2 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 3.8 |
15.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 3.7 |
11.2 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 3.7 |
22.3 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 3.7 |
58.6 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 3.4 |
13.8 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 3.4 |
13.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 3.4 |
3.4 |
GO:0061324 |
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 3.3 |
13.4 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 3.3 |
16.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 3.2 |
9.7 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 3.2 |
35.7 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 3.1 |
6.2 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 3.1 |
12.3 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 3.0 |
9.1 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 3.0 |
20.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 3.0 |
11.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 3.0 |
26.6 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 2.9 |
17.7 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 2.9 |
23.5 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 2.9 |
46.0 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 2.9 |
8.6 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 2.8 |
14.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 2.8 |
11.3 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 2.8 |
19.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 2.6 |
7.8 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 2.6 |
10.3 |
GO:0061428 |
embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 2.6 |
7.7 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 2.5 |
25.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 2.5 |
9.8 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 2.4 |
12.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 2.3 |
7.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 2.3 |
9.2 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 2.3 |
9.2 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 2.3 |
25.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 2.3 |
9.0 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.2 |
6.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 2.1 |
6.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 2.0 |
6.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 2.0 |
10.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 2.0 |
11.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 2.0 |
7.9 |
GO:2000427 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.9 |
5.8 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.9 |
5.8 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.9 |
5.7 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 1.9 |
16.7 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 1.8 |
7.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 1.8 |
7.3 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.8 |
9.0 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 1.8 |
23.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.8 |
3.6 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 1.8 |
10.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.8 |
5.3 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 1.8 |
7.0 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 1.7 |
3.4 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 1.7 |
3.4 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 1.7 |
5.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.7 |
6.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 1.7 |
25.4 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 1.7 |
23.6 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 1.6 |
4.9 |
GO:0021699 |
cerebellar cortex maturation(GO:0021699) |
| 1.6 |
4.9 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 1.6 |
9.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 1.6 |
15.7 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 1.6 |
53.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 1.5 |
3.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.4 |
11.4 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 1.4 |
25.3 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 1.4 |
28.0 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 1.4 |
9.8 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.4 |
5.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.4 |
4.1 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 1.3 |
5.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.3 |
6.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 1.3 |
6.6 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 1.3 |
17.2 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.3 |
6.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.3 |
7.9 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 1.3 |
10.5 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 1.3 |
2.6 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
| 1.3 |
3.9 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 1.3 |
23.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 1.3 |
3.9 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.3 |
14.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 1.3 |
17.8 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 1.3 |
16.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.3 |
49.5 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 1.2 |
5.0 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.2 |
4.9 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 1.2 |
13.6 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 1.2 |
2.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.2 |
4.8 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.2 |
2.4 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 1.2 |
8.4 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.2 |
3.6 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.2 |
1.2 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 1.2 |
17.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 1.2 |
16.3 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 1.2 |
47.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 1.1 |
26.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 1.1 |
3.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.1 |
19.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 1.1 |
12.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 1.1 |
6.5 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.1 |
3.2 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 1.1 |
20.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 1.1 |
7.5 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.1 |
4.3 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 1.1 |
2.1 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.1 |
20.0 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 1.0 |
4.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 1.0 |
5.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 1.0 |
9.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.0 |
5.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 1.0 |
7.0 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.0 |
15.8 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 1.0 |
6.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.0 |
31.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 1.0 |
15.2 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.9 |
5.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.9 |
4.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.9 |
3.7 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.9 |
9.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.9 |
14.7 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.9 |
2.7 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.9 |
0.9 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.9 |
16.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.9 |
2.6 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.9 |
3.5 |
GO:0003192 |
mitral valve formation(GO:0003192) condensed mesenchymal cell proliferation(GO:0072137) |
| 0.9 |
2.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.9 |
4.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.9 |
8.5 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.8 |
6.8 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.8 |
2.5 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.8 |
4.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.8 |
0.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.8 |
5.6 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.8 |
3.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 |
10.2 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.8 |
21.9 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.8 |
3.9 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.8 |
9.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.8 |
3.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.8 |
3.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.8 |
6.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.7 |
2.2 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.7 |
3.0 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.7 |
1.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.7 |
5.9 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 |
50.9 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.7 |
8.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.7 |
3.6 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.7 |
0.7 |
GO:0061551 |
cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
| 0.7 |
2.1 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.7 |
9.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.7 |
5.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.7 |
7.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.7 |
4.8 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.7 |
6.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.7 |
4.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.7 |
8.6 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.7 |
6.6 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.7 |
3.3 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.7 |
1.3 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.6 |
3.9 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.6 |
3.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.6 |
7.6 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.6 |
3.1 |
GO:0046880 |
progesterone secretion(GO:0042701) regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.6 |
3.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.6 |
5.5 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.6 |
8.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.6 |
6.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.6 |
10.9 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.6 |
4.8 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.6 |
8.8 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.6 |
1.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.6 |
1.7 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.6 |
3.5 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.6 |
5.8 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.6 |
4.0 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.6 |
0.6 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.6 |
3.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 |
4.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.6 |
5.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.6 |
3.4 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.6 |
3.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.6 |
5.0 |
GO:0035280 |
miRNA mediated inhibition of translation(GO:0035278) miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.6 |
6.1 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.6 |
1.1 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.5 |
4.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.5 |
2.7 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 |
3.8 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.5 |
2.7 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.5 |
7.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.5 |
1.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.5 |
1.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.5 |
7.5 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.5 |
3.2 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.5 |
13.2 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.5 |
1.0 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.5 |
10.5 |
GO:0060384 |
innervation(GO:0060384) |
| 0.5 |
3.6 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.5 |
2.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.5 |
14.5 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.5 |
8.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 |
7.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.5 |
2.5 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.5 |
14.0 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.5 |
2.0 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.5 |
10.9 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.5 |
2.9 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.5 |
35.0 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.5 |
1.9 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.5 |
12.9 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.5 |
3.8 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.5 |
2.8 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.5 |
6.6 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.5 |
4.7 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.5 |
2.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.5 |
3.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.5 |
16.7 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.5 |
2.7 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.5 |
3.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.5 |
28.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.5 |
2.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.4 |
29.7 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.4 |
2.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.4 |
7.6 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.4 |
4.4 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.4 |
2.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.4 |
1.3 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.4 |
3.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.4 |
5.6 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.4 |
8.5 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.4 |
5.4 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.4 |
2.1 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.4 |
2.1 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.4 |
0.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.4 |
2.0 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 |
0.8 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.4 |
1.2 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 |
6.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.4 |
1.2 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 |
4.0 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.4 |
45.9 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.4 |
0.8 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.4 |
1.6 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.4 |
14.2 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.4 |
7.9 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 |
1.1 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.4 |
2.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 |
1.4 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.4 |
0.7 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.4 |
7.5 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.4 |
18.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.3 |
10.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
3.4 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 |
6.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
3.4 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.3 |
3.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
4.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
2.4 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.3 |
7.7 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.3 |
1.0 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.3 |
2.3 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 |
5.0 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 |
5.0 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.3 |
5.0 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.3 |
4.6 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.3 |
2.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.3 |
10.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
2.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
1.0 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
1.9 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.3 |
0.9 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.3 |
2.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.3 |
0.9 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.3 |
0.9 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 |
0.9 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 |
0.9 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.7 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.3 |
1.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.3 |
3.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 |
1.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.3 |
1.7 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.3 |
23.2 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.3 |
15.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.3 |
2.5 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.3 |
1.9 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 |
2.7 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.3 |
6.1 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.5 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.3 |
8.0 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 |
2.0 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 |
3.2 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.2 |
1.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
3.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
5.0 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 |
3.6 |
GO:0006308 |
DNA catabolic process(GO:0006308) DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
1.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
7.7 |
GO:0097202 |
activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.2 |
3.0 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
4.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
1.4 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) iris morphogenesis(GO:0061072) |
| 0.2 |
6.0 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.2 |
1.8 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
13.6 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.2 |
5.9 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.2 |
1.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
15.5 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.2 |
9.2 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.2 |
0.9 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.2 |
9.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.2 |
1.8 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.2 |
15.3 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
| 0.2 |
39.6 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.2 |
3.0 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.2 |
3.1 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.2 |
6.0 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
2.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
1.9 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
5.6 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.2 |
8.4 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
| 0.2 |
5.5 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.2 |
3.7 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.2 |
1.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
1.8 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
2.3 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
35.4 |
GO:0006644 |
phospholipid metabolic process(GO:0006644) |
| 0.2 |
1.0 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
5.0 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.2 |
0.7 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.2 |
3.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.2 |
2.6 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
3.5 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.2 |
9.0 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.2 |
0.3 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.2 |
2.6 |
GO:0060479 |
lung cell differentiation(GO:0060479) |
| 0.2 |
2.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
2.9 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.1 |
0.9 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
2.0 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.1 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
1.5 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
4.3 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 |
1.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
2.8 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.1 |
0.9 |
GO:0090190 |
positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 |
1.0 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
2.0 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
1.0 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.5 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
1.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
1.5 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.2 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
1.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
14.8 |
GO:0018105 |
peptidyl-serine phosphorylation(GO:0018105) |
| 0.1 |
2.8 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
5.6 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.1 |
0.9 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.6 |
GO:0060088 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
2.6 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
4.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
4.0 |
GO:0048167 |
regulation of synaptic plasticity(GO:0048167) |
| 0.1 |
1.6 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
3.7 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
3.2 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 |
0.7 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
3.3 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.5 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.1 |
0.5 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.8 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
5.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
1.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.6 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
1.4 |
GO:0010634 |
positive regulation of epithelial cell migration(GO:0010634) |
| 0.1 |
1.2 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
1.0 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
1.5 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.0 |
0.3 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
1.1 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
1.6 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
3.6 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.2 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.0 |
0.5 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.5 |
GO:0018393 |
internal peptidyl-lysine acetylation(GO:0018393) |
| 0.0 |
1.1 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
1.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
3.6 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.6 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.9 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.1 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
2.1 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.8 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.3 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.1 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 |
2.0 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.4 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.1 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
